Visfatin/pre-B-cell colony-enhancing factor: A protein with various suggested functions

Journal of Endocrinological Investigation

Volumn 30, Issue 2, 2007, Pages 138-144

  Pilz, Stefan ^a,c   Mangge, H ^a   Obermayer Pietsch, B ^a   Marz W ^b  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b SYNLAB ACADEMY   (Germany)

^c NONE   (Austria)

Author keywords

Adipokines; Obesity; PBEF; Pre B cell colony enhancing factor; Visfatin

Indexed keywords

ADIPOCYTOKINE; BIOLOGICAL MARKER; CYCLOPHOSPHAMIDE; DOXORUBICIN; INSULIN RECEPTOR; NICOTINAMIDE ADENINE DINUCLEOTIDE; VISFATIN;

ACUTE LUNG INJURY; APOPTOSIS; B LYMPHOCYTE; BREAST CANCER; CELL CYCLE REGULATION; CELL MATURATION; COLORECTAL CANCER; DOWN REGULATION; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; IMMUNE SYSTEM; INTRAABDOMINAL FAT; LABOR; LYMPHOCYTE DIFFERENTIATION; METABOLISM; NEUTROPHIL; NONHUMAN; PATHOPHYSIOLOGY; PREGNANCY; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; REVIEW; SEPSIS; SMOOTH MUSCLE FIBER; UPREGULATION; VASCULAR SMOOTH MUSCLE;

EID: 34247223066     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03347412     Document Type: Review

References (50)

1. Kershaw EE, Flier SF. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004, 89: 2548-56.
2. Samal B, Sun Y, Steams G, Xie C, Suggs S, McNiece I. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol 1994, 14: 1431-7.
3. Ognjanovic S, Bao S, Yamamoto SY, Garibay-Tupas J, Samal B, Bryant-Greenwood GD. Genomic organization of the gene coding for human pre-B-cel colony enhancing factor and expression in human fetal membranes. J Mol Endocrinol 2001, 26: 107-17.
4. Kitani T, Okuno S, Fujisawa H. Growth phase-dependent changes in the subcellular localization of pre-B-cell colony-enhancing factor. FEBS 2003, 544: 74-8.
5. Mc Glothlin JR, Gao L, Lavoie T, et al. Molecular cloning and characterization of canine pre-B-cell colony-enhancing factor. Biochem Genet 2005, 43: 127-41.
6. Fujiki K, Shin DH, Nakao M, Yano T. Molecular cloning and expression analysis of the putative carp (Cyprinus carpio) pre-B cell enhancing factor. Fish Shellfish Immunol 2000, 10: 383-5.
7. Martin PR, Shea RJ, Mulks MH. Identification of a plasmid-encoded gene from haemophilus ducreyi which confers NAD independence. J Bacteriol 2001, 183: 1168-74.
8. Muller WE, Perovic S, Wilkesman J, Kruse M, Muller IM, Batel R. Increased gene expression of a cytokine-related molecule and profilin after activation of Suberites domuncula cells with xenogeneic sponge molecule(s). DNA Cell Biol 1999, 18: 885-93.
9. Muller WE, Wiens M, Muller IM, Schroeder HC. The chemokine network in sponges: potential roles in morphogenesis, immunity and stem cell formation. Prog Mol Subcell Biol 2004, 34: 103-43.
10. Ye SQ, Simon BA, Maloney JP, et al. Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury. Am J Respir Crit Care Med 2005, 171: 361-70.
11. Shin DH, Oganesyan N, Jancarik J, Yokota H, Kim R, Kim SH. Crystal structure of a nicotinate phosphoribosyltransferase from Thermoplasma acidophilum. J Biol Chem 2005, 18: 18326-35.
12. Patrone L, Damore MA, Lee MB, Malone CS, Wall R. Genes expressed during the IFNγ-induced maturation of pre-B cells. Mol Immunol 2002, 38: 597-606.
13. Xu LG, Wu M, Hu J, Zhai Z, Shu HB. Identification of downstream genes up-regulated by the tumor necrosis factor family member TALL-1. J Leukoc Biol 2002, 72: 410-6.
14. Turpaev K, Bouton C, Diet A, Glatigny A, Drapier JC. Analysis of differentially expressed genes in nitric oxide-exposed human monocytic cells. Free Radic Biol Med 2005, 38: 1392-400.
15. Jia SH, Li Y, Parodo J, et al. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest 2004, 113: 1318-27.
16. Ye SQ, Zhang LQ, Adyshev D, et al. Pre-B-cell-colony-enhancing factor is critically involved in thrombin-induced lung endothelial cell barrier dysregulation. Microvasc Res 2005, 10: 142-51.
17. Koczan D, Guthke R, Thiesen HJ, et al. Gene expression profiling of peripheral blood mononuclear leukocytes from psoriasis patients identifies new immune regulatory molecules. Eur J Dermatol 2005, 15: 251-7.
18. Otero M, Lago R, Gomez R, et al. Changes in fat-derived hormones plasma concentrations: adiponectin, leptin, resistin, and visfatin in rheumatoid arthritis subjects. Ann Rheum Dis 2006, 65: 1798-201.
19. Nemeth E, Tashima LS, Yu Z, Bryant-Greenwood GD. Fetal membrane distension I. Differentially expressed genes regulated by acute distension in amniotic epithelial (WISH) cells. Am J Obstet Gynecol 2000, 182: 50-9.
20. Ognjanovic S, Bryant-Greenwood GD. Pre-B-cell colony-enhancing factor, a novel cytokine of human fetal membranes. Am J Obstet Gynecol 2002, 187: 1051-8.
21. Marvin KW, Keelan JA, Eykholt RL, Sato TA, Mitchell MD. Use of cDNA arrays to generate differential expression profiles for inflammatory genes in human gestational membranes delivered at term and preterm. Mol Hum Reprod 2002, 8: 399-408.
22. Ognjanovic S, Tashima LS, Bryant-Greenwood GD. The effects of pre-B-cell colony-enhancing factor on the human fetal membranes by microarray analysis. Am J Obstet Gynecol 2003, 189: 1187-95.
23. Ognjanovic S, Ku TL, Bryant-Greenwood GD. Pre-B-cell colony-enhancing factor is a secreted cytokine-like protein from the human amniotic epithelium. Am J Obstet Gynecol 2005, 193: 273-82.
24. Krzyzanowska K, Krugluger W, Mittermayer F, et al. Increased visfatin concentrations in women with gestational diabetes. Clin Sci (Lond) 2006, 110: 605-9.
25. Hufton SE, Moerkerk PT, Brandwijk R, deBruine AP, Arends JW, Hoogenboom HR. A profile of differentially expressed genes in primary colorectal cancer using suppression substractive hybridization. FEBS 1999, 463: 77-82.
26. van Beijnum JR, Moerkerk PT, Gerbers AJ, et al. Target validation for genomics using peptide-specific phage antibodies: a study of five gene products overexpressed in colorectal cancer. Int J Cancer 2002, 101: 118-27.
27. Folgueira MA, Carraro DM, Brentani H, et al. Gene expression profile associated with response to doxorubicin-based therapy in breast cancer. Clin Cancer Res 2005, 11: 7434-43.
28. Rongvaux A, Shea RJ, Mulks MH, et al. Pre-B-cell enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis. Eur J Immunol 2002, 32: 3225-34.
29. van der Veer E, Nong Z, O'Neil C, Urquhart B, Freeman D, Pickering JG. Pre-B-cell colony-enhancing factor regulates NAD+-dependent protein deacetylase activity and promotes vascular smooth muscle cell maturation. Circ Res 2005, 97: 25-34.
30. Archer SL. Pre-B-cell colony-enhancing factor regulates vascular smooth muscle maturation through a NAD+-dependent mechanism. Circ Res 2005, 97: 4-7.
31. Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: A protein secreted by visceral fat that mimics the effects of insulin. Science 2005, 307: 426-30.
32. Curat CA, Wegner V, Senges C, et al. Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 2006, 49: 744-7.
33. Chen MP, Chung FM, Chang DM, et al. Elevated plasma levels of visfatin/ pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 2006, 91: 295-9.
34. Berndt J, Klöting N, Kralisch S, et al. Plasma visfatin concentrations and fat depot-specific mRNA expressions in humans. Diabetes 2005, 54: 2911-6.
35. Hammarstedt A, Pihlajamäki J, Sopasakis VR, et al. Visfatin is an adipokine but it is not regulated by thiazolidinediones. J Clin Endocrinol Metab 2006, 91: 1181-4.
36. Haider DG, Schindler K, Schaller G, Prager G, Wolzt M, Ludvik B. Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J Clin Endocrinol Metab 2006, 91: 1578-81.
37. Klöting N, Klöting I. Visfatin: Gene expression in isolated adipocytes and sequence analysis in obese WOKW rats compared with lean control rats. Biochem Biophys Res Commun 2005, 332: 1070-2.
38. Ando H, Yanagihara H, Hayashi Y, et al. Rhytmic mRNA expression of clock genes and adipocytokines in mouse visceral adipose tissue. Endocrinology 2005, 146: 5631-6.
39. Kralisch S, Klein J, Lossner U, et al. Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes. J Endocrinol 2005, 185: R1-R8.
40. Kralisch S, Klein J, Lossner U, et al. Interleukin-6 is a negative regulator of visfatin gene expression in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 2005, 289: 586-90.
41. Choi KC, Ryu OH, Lee KVV, et al. Effect of PPAR-α and -γ agonist on the expression of visfatin, adiponectin, and TNF-α in visceral fat of OLETF rats. Biochem Biophys Res Commun 2005, 336: 747-53.
42. Tang H, Cheung WM, Ip FC, Ip NY. Identification and charcterization of differentially expressed genes in denervated muscle. Mol Cell Neurosci 2000, 16: 127-40.
43. Hug C, Lodisch HF. Visfatin: A new adipocytokine. Science 2005, 307: 366-7.
44. Stephens JM, Vidal-Puig AJ. An update on visfatin/pre-B cell colony-enhancing factor, an ubiquitously expressed, illusive cytokine that is regulated in obesity. Curr Opin Lipidol 2006, 17: 128-31.
45. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005, 115: 911-9.
46. Lin SJ, Guarente L. Nicotinamide adenine dinucleotide, a metabolic regulator of transcription, longevity and disease. Curr Opin Cell Biol 2003, 15: 241-6.
47. Guarente L, Picard F. Calorie restriction - the SIR2 connection. Cell 2005, 120: 473-82.
48. Pilz S, Horejsi R, Möller R, et al. Early atherosclerosis in obese juveniles is associated with low serum levels of adiponectin. J Clin Endocrinol Metab 2005, 90: 4792-6.
49. Libby P. Inflammation in atherosclerosis. Nature 2002, 420: 868-74.
50. Avogaro A, de Kreutzenberg SV. Mechanisms of endothelial dysfunction in obesity. Clin Chim Acta 2005, 360: 9-26.